ProCE Banner Activity

Considerations for Treatment of Ulcerative Colitis: The Role of Ozanimod

Clinical Thought

A gastroenterology expert discusses S1P receptor modulators and how they fit into optimizing the care for patients with ulcerative colitis.

Released: March 16, 2023

Expiration: March 14, 2024

Share

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Bristol Myers Squibb

Faculty Disclosure

Jordan Axelrad, MD, MPH: consultant/advisor/speaker: AbbVie, Adiso, Bristol-Myers Squibb, Fresenius, Janssen, Pfizer.